FGFR1 amplification is described as an early event in breast cancer initiation and dysregulated FGFR1 signaling is frequently occurring in breast cancer, and FGFR1 is a target for investigation in ongoing clinical trials for breast cancer therapy (17). The gene discussed is FGFR1; the disease is breast cancer.